崔昊，药物化学博士，校聘副教授，硕士生导师，毕业于中国药科大学，主要研究方向为小分子抗肿瘤药物的设计、合成及生物活性研究。参与多项国家自然基金项目及省级项目。

联系方式：cuih1008@ahmu.edu.cn

主要科研项目：

安徽省高校自然科学研究项目，2022AH050654；2023.1-2024.12，主持；

2022年引进人才博士科研启动经费，0601113201。

主要发表论文：

Hao Cui^#, Qianqian Hong^#, Ran Wei, Hongmei Li, Chunyang Wan, Xin Chen, Shuang Zhao, Haizhi Bu, Bingxu Zhang, Dexiao Yang, Tao Lu*, Yadong Chen*, Yong Zhu*. Design and synthesis of HDAC inhibitors to enhance the therapeutic effect of diffuse large B-cell lymphoma by improving metabolic stability and pharmacokinetic characteristics. European Journal of Medicinal Chemistry. 2022 5(229): 114049.

Hao Cui, Jingkun Huang, Yan Lei, Quanwei Chen, Zan Hu, Jiaqi Niu, Ran Wei, Kang Yang, Hongmei Li, Tao Lu*, Yong Zhu*, Yatian Huang*. Design and synthesis of dual inhibitors targeting snail and histone deacetylase for the treatment of solid tumour cancer. European Journal of Medicinal Chemistry. 2022 5(229): 114082.

Hao Cui^#, Zan Hu^#, Kang Yang, Jingkun Huang, Yichao Wu, Quanwei Chen, Ran Wei, Penfeng Wang, Hui Wang, Tao Lu*, Yuqin Yao*, Yong Zhu*. Design and synthesis of highly TRAIL expression HDAC inhibitors based on ONC201 to promote apoptosis of colorectal cancer. European Journal of Medicinal Chemistry. 2022 10(238): 114568.